99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Microbiome-based technologies drive multibillion-dollar market

Microbiome-based technologies drive multibillion-dollar market

by André Julião,FAPESPNew research field promises to transform food production and treatment of diseases. A global panel of experts unified concepts to define research priorities and offer basis

Microbiome-based technologies drive multibillion-dollar market

by André Julião,FAPESPNew research field promises to transform food production and treatment of diseases. A global panel of experts unified concepts to define research priorities and offer basis
Uncovering the Heart-Brain-Immune Connection: How Sleep Promotes Healing After a Heart Attack

Uncovering the Heart-Brain-Immune Connection: How Sleep Promotes Healing After a Heart Attack

Recent discoveries in cardiovascular and neurological research have uncovered a fascinating new link between the heart, brain, and immune system.

Uncovering the Heart-Brain-Immune Connection: How Sleep Promotes Healing After a Heart Attack

Recent discoveries in cardiovascular and neurological research have uncovered a fascinating new link between the heart, brain, and immune system.
Autophagy-tethering compounds may open new directions in targeted drug discovery

Autophagy-tethering compounds may open new directions in targeted drug discovery

byScience China Press(A) Molecular glue ATTECs are targeting polyQ proteins in neurodegenerative disorders. (B) Bifunctional ATTECs targeting oncoprotein BRD4. (C) Bifunctional ATTECs targeting

Autophagy-tethering compounds may open new directions in targeted drug discovery

byScience China Press(A) Molecular glue ATTECs are targeting polyQ proteins in neurodegenerative disorders. (B) Bifunctional ATTECs targeting oncoprotein BRD4. (C) Bifunctional ATTECs targeting
Health care database analysis highlights lingering symptoms long after COVID-19 infection

Health care database analysis highlights lingering symptoms long after COVID-19 infection

byUniversity of OxfordIncidence rate of post-acute COVID-19 symptoms in the infected cohort. Note: Plots have been scaled independently so that all incidences can be visualized. Credit:eCl

Health care database analysis highlights lingering symptoms long after COVID-19 infection

byUniversity of OxfordIncidence rate of post-acute COVID-19 symptoms in the infected cohort. Note: Plots have been scaled independently so that all incidences can be visualized. Credit:eCl
Plozasiran reduces triglyceride levels by 74% at 24 weeks

Plozasiran reduces triglyceride levels by 74% at 24 weeks

byAmerican College of CardiologyCredit: CC0 Public DomainIn patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran red

Plozasiran reduces triglyceride levels by 74% at 24 weeks

byAmerican College of CardiologyCredit: CC0 Public DomainIn patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran red
Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

by ByJay Furst,Mayo ClinicGraphical abstract. Credit:Mayo Clinic Proceedings(2023). DOI: 10.1016/j.mayocp.2023.08.012Patients who received the anticoagulant drug warfarin after biopr

Use of anticoagulant drug after aortic valve replacement lowers mortality risk, study finds

by ByJay Furst,Mayo ClinicGraphical abstract. Credit:Mayo Clinic Proceedings(2023). DOI: 10.1016/j.mayocp.2023.08.012Patients who received the anticoagulant drug warfarin after biopr
New treatment options for advanced myelofibrosis and other blood malignancies show promise

New treatment options for advanced myelofibrosis and other blood malignancies show promise

byUniversity of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainFew standard treatments have been available for advanced myelofibrosis, a bone marrow disorder characterized by

New treatment options for advanced myelofibrosis and other blood malignancies show promise

byUniversity of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainFew standard treatments have been available for advanced myelofibrosis, a bone marrow disorder characterized by
New software tool decodes cytokine 'language' of immune cells

New software tool decodes cytokine 'language' of immune cells

by Julie Parry,Yale School of MedicineOverview of the CINEMA-OT framework. a, scRNA-seq count data is first decomposed into confounder variation and treatment-associated variation using ICA. Cel

New software tool decodes cytokine 'language' of immune cells

by Julie Parry,Yale School of MedicineOverview of the CINEMA-OT framework. a, scRNA-seq count data is first decomposed into confounder variation and treatment-associated variation using ICA. Cel
New drug helps narrow racial survival disparity in patients with acute myeloid leukemia: Study

New drug helps narrow racial survival disparity in patients with acute myeloid leukemia: Study

by Perelman School of Medicine at the University of PennsylvaniaBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaNon-Hispanic Black patients wi

New drug helps narrow racial survival disparity in patients with acute myeloid leukemia: Study

by Perelman School of Medicine at the University of PennsylvaniaBone marrow aspirate showing acute myeloid leukemia. Several blasts have Auer rods. Credit: WikipediaNon-Hispanic Black patients wi
New insight into the protein mutations that cause Rett syndrome

New insight into the protein mutations that cause Rett syndrome

byRockefeller UniversityWorking model for normal MeCP2 function on chromatin and its dysregulation in disease. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s4

New insight into the protein mutations that cause Rett syndrome

byRockefeller UniversityWorking model for normal MeCP2 function on chromatin and its dysregulation in disease. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s4
New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis

New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis

by Isabella Backman,Yale UniversityThe lab of Choukri Ben Mamoun, PhD (left), has a long-standing interest in fighting this tick-borne disease. Credit: Yale UniversityDrug-resistant babesiosis m

New combination therapy found effective against drug-sensitive and resistant tick-borne babesiosis

by Isabella Backman,Yale UniversityThe lab of Choukri Ben Mamoun, PhD (left), has a long-standing interest in fighting this tick-borne disease. Credit: Yale UniversityDrug-resistant babesiosis m